Trial Profile
Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Jan 2010
Price :
$35
*
At a glance
- Drugs Ezatiostat (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- Sponsors Telik
- 27 Jan 2010 New trial record
- 25 Jan 2010 Results have been published in the Journal of Hematology and Oncology according to a Telik media release.